nafamostat has been researched along with cyclic gmp in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, H; Sunamori, M; Suzuki, A; Wang, Y; Yoshida, T | 1 |
| Hatakeyama, H; Ikeda, J; Kojima, S; Kuramochi, M; Naganawa, M; Ogi, M; Yoshitomi, Y | 1 |
| Kojima, S; Kuramochi, M; Matsumoto, Y; Sugi, T; Yano, M; Yoshitomi, Y | 1 |
3 other study(ies) available for nafamostat and cyclic gmp
| Article | Year |
|---|---|
The effect and pharmacokinetics of nafamostat mesilate adjunct to cold nondepolarizing cardioplegia in a canine model of cardiac preservation.
Topics: Adenine Nucleotides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamidines; Cardioplegic Solutions; Cyclic AMP; Cyclic GMP; Dogs; Energy Metabolism; Guanidines; Heart; Heart Transplantation; Hypothermia, Induced; Lysosomes; Myocardium; Organ Preservation; Phosphocreatine; Protease Inhibitors; Ventricular Function, Left | 1996 |
Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
Topics: 6-Ketoprostaglandin F1 alpha; Anticoagulants; Benzamidines; Blood Component Removal; Bradykinin; Cyclic GMP; Dextran Sulfate; Dinoprostone; Factor XII; Guanidines; Heparin; Humans; Hyperlipoproteinemia Type II; Kallikreins; Kininogens; Lipoproteins, LDL; Male; Middle Aged; Prekallikrein | 1997 |
Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
Topics: Adrenomedullin; Anticoagulants; Benzamidines; Blood Component Removal; Bradykinin; Cyclic AMP; Cyclic GMP; Dextran Sulfate; Guanidines; Heparin; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide; Nucleotides, Cyclic; Peptides; Prostaglandins | 1998 |